Table 3 Initial antifungal therapy and outcomes of 26 patients with CNS involvement
Variables | No. (%) of patients (N = 26) |
|---|---|
Initial antifungal therapy | |
AmB based | 18 (69.2) |
Fluconazole based | 5 (19.2) |
Othera | 3 (11.6) |
Efficacy of initial antifungal therapy | |
Success | 11 (42.3) |
Complete response | 0 |
Partial response | 11 (42.3) |
Failure | 15 (57.7) |
Stable | 10 (38.5) |
Progression | 1 (3.8) |
Death | 4 (15.4) |
Outcomeb | |
2-week mortality rate | 3/26 (11.6%) |
10-week mortality rate | 5/25 (20.0%) |
1-year survival rate | 18/25 (72.0%) |